Melatonin uptake through glucose transporters: A new target for melatonin inhibition of cancer

Journal of Pineal Research

Volumn 58, Issue 2, 2015, Pages 234-250

  Hevia, David ^a   González Menéndez, Pedro ^a   Quiros González, Isabel ^b   Miar, Ana ^a   Rodríguez García, Aida ^a   Tan, Dun Xian ^c   Reiter, Russel J ^c   Mayo, Juan C ^a   Sainz, Rosa M ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c University of Texas Health Science Center   (United States)

Author keywords

cancer; glucose; glucose transporter; Melatonin; prostate; transgenic adenocarcinoma of the mouse prostate; transporter

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOSPORIN A; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; MELATONIN; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONE DETERMINATION; HUMAN; HUMAN CELL; LIFESPAN; MALE; MOLECULAR DOCKING; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; REGULATORY MECHANISM; ANIMAL; CELL MEMBRANE; METABOLISM; PROSTATIC NEOPLASMS; RAT; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; MALE; MELATONIN; MICE; PROSTATIC NEOPLASMS; RATS;

EID: 84922814928     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12210     Document Type: Article

References (61)

1. Hardeland R, Poeggeler B,. Non-vertebrate melatonin. J Pineal Res 2003; 34: 233-241.
2. Acuna-Castroviejo D, Escames G, Venegas C, et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci 2014; 71: 2997-3025.
3. Reiter RJ, Vaughn MK, Blask DE, et al. Melatonin: its inhibition of pineal antigonadotrophic activity in male hamsters. Science 1974; 185: 1169-1171.
4. Reiter RJ, Tan DX, Manchester LC, et al. Melatonin and reproduction revisited. Biol Reprod 2009; 81: 445-456.
5. Tan DX, Hardeland R, Manchester LC, et al. The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol Rev Camb Philos Soc 2010; 85: 607-623.
6. Mayo JC, Sainz RM, Tan DX, et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005; 165: 139-149.
7. Hardeland R, Madrid JA, Tan DX, et al. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 2012; 52: 139-166.
8. Reppert SM, Godson C, Mahle CD, et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A 1995; 92: 8734-8738.
9. Dubocovich ML, Masana MI,. Benloucif, S Molecular pharmacology and function of melatonin receptor subtypes. Adv Exp Med Biol 1999; 460: 181-190.
10. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, et al. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 2012; 351: 152-166.
11. Nosjean O, Ferro M, Coge F, et al. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000; 275: 31311-31317.
12. Benitez-King G, Huerto-Delgadillo L, Anton-Tay F,. Binding of 3H-melatonin to calmodulin. Life Sci 1993; 53: 201-207.
13. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 1994; 269: 28531-28534.
14. Dubocovich ML, Delagrange P, Krause DN, et al. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 2010; 62: 343-380.
15. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
16. Tan DX, Manchester LC, Liu X, et al. Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes. J Pineal Res 2013; 54: 127-138.
17. Tan DX, Hardeland R, Manchester LC, et al. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 2003; 34: 249-259.
18. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
19. Tan DX, Manchester LC, Hardeland R, et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34: 75-78.
20. Acuna Castroviejo D, Lopez LC, Escames G, et al. Melatonin-mitochondria interplay in health and disease. Curr Top Med Chem 2011; 11: 221-240.
21. Arnao MB, Hernandez-Ruiz J,. Protective effect of melatonin against chlorophyll degradation during the senescence of barley leaves. J Pineal Res 2009; 46: 58-63.
22. Zhang N, Zhao B, Zhang HJ, et al. Melatonin promotes water-stress tolerance, lateral root formation, and seed germination in cucumber (Cucumis sativus L.). J Pineal Res 2013; 54: 15-23.
23. Martin M, Macias M, Escames G, et al. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB J 2000; 14: 1677-1679.
24. Venegas C, Garcia JA, Escames G, et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52: 217-227.
25. Costa EJ, Shida CS, Biaggi MH, et al. How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Lett 1997; 416: 103-106.
26. Garcia JJ, Lopez-Pingarron L, Almeida-Souza P, et al. Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res 2014; 56: 225-237.
27. Hevia D, Sainz RM, Blanco D, et al. Melatonin uptake in prostate cancer cells: intracellular transport versus simple passive diffusion. J Pineal Res 2008; 45: 247-257.
28. Hevia D, Mayo JC, Quiros I, et al. Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC. Anal Bioanal Chem 2010; 397: 1235-1244.
29. Escamilla-Gomez V, Hernandez-Santos D, Gonzalez-Garcia MB, et al. Simultaneous detection of free and total prostate specific antigen on a screen-printed electrochemical dual sensor. Biosens Bioelectron 2009; 24: 2678-2683.
30. Sun L, Zeng X, Yan C, et al. Crystal structure of a bacterial homologue of glucose transporters GLUT1-4. Nature 2012; 490: 361-366.
31. Thomsen R, Christensen MH,. MolDock: a new technique for high-accuracy molecular docking. J Med Chem 2006; 49: 3315-3321.
32. Gonzalez-Menendez P, Hevia D, Rodriguez-Garcia A, et al. Regulation of GLUT transporters by flavonoids in androgen-sensitive and insensitive prostate cancer cells. Endocrinology 2014; 155: 3238-3250.
33. Greenberg NM, Demayo F, Finegold MJ, et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A 1995; 92: 3439-3443.
34. Sainz RM, Mayo JC, Tan DX, et al. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate 2005; 63: 29-43.
35. Quiros-Gonzalez I, Sainz RM, Hevia D, et al. MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells. Free Radic Biol Med 2011; 50: 525-536.
36. Reinicke K, Sotomayor P, Cisterna P, et al. Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue. J Cell Biochem 2012; 113: 553-562.
37. Mueckler M, Thorens B,. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 2013; 34: 121-138.
38. Thorens B, Mueckler M,. Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 2010; 298: E141-E145.
39. Carruthers A, Dezutter J, Ganguly A, et al. Will the original glucose transporter isoform please stand up!. Am J Physiol Endocrinol Metab 2009; 297: E836-E848.
40. Maher F, Vannucci SJ, Simpson IA,. Glucose transporter proteins in brain. FASEB J 1994; 8: 1003-1011.
41. Fukumoto H, Seino S, Imura H, et al. Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc Natl Acad Sci U S A 1988; 85: 5434-5438.
42. Bibert S, Hess SK, Firsov D, et al. Mouse GLUT9: evidences for a urate uniporter. Am J Physiol Renal Physiol 2009; 297: F612-F619.
43. Uldry M, Steiner P, Zurich MG, et al. Regulated exocytosis of an H+/myo-inositol symporter at synapses and growth cones. EMBO J 2004; 23: 531-540.
44. Vera JC, Rivas CI, Velasquez FV, et al. Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid. J Biol Chem 1995; 270: 23706-23712.
45. Kc S, Carcamo JM, Golde DW,. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J 2005; 19: 1657-1667.
46. Widmer J, Raffin Y, Gaillard JM, et al. Reversible in vitro decrease of L-tyrosine and L-tryptophan influx across the human erythrocyte membrane induced by cytochalasin B, the specific inhibitor of D-glucose transport. Neuropsychobiology 1990; 24: 67-73.
47. Lagerquist Hagglund C, Lundahl P,. Centrifugal and chromatographic analyses of tryptophan and tyrosine uptake by red blood cells and GLUT1 proteoliposomes with permeability estimates and observations on dihydrocytochalasin B. J Biochem Biophys Methods 2003; 55: 127-140.
48. Kurlbaum M, Mulek M, Hogger P,. Facilitated uptake of a bioactive metabolite of maritime pine bark extract (pycnogenol) into human erythrocytes. PLoS One 2013; 8: e63197.
49. Macheda ML, Rogers S, Best JD,. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2005; 202: 654-662.
50. Saija A, Tomaino A, Trombetta D, et al. Interaction of melatonin with model membranes and possible implications in its photoprotective activity. Eur J Pharm Biopharm 2002; 53: 209-215.
51. Reiter RJ, Tan DX, Manchester LC, et al. Melatonin in edible plants (phytomelatonin): identification, concentrations, bioavailability and proposed functions. World Rev Nutr Diet 2007; 97: 211-230.
52. Reiter RJ, Rosales-Corral SA, Manchester LC, et al. Melatonin in the biliary tract and liver: health implications. Curr Pharm Des 2014; 20: 4788-4801.
53. Fischer TW, Sweatman TW, Semak I, et al. Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J 2006; 20: 1564-1566.
54. Gainetdinov RR, Caron MG,. Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 2003; 43: 261-284.
55. Blask DE, Brainard GC, Dauchy RT, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005; 65: 11174-11184.
56. Cos S, Sanchez-Barcelo EJ,. Melatonin, experimental basis for a possible application in breast cancer prevention and treatment. Histol Histopathol 2000; 15: 637-647.
57. Jiang T, Chang Q, Zhao Z, et al. Melatonin-mediated cytoprotection against hyperglycemic injury in Muller cells. PLoS One 2012; 7: e50661.
58. Bonnefond A, Clement N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 2012; 44: 297-301.
59. Manolescu AR, Witkowska K, Kinnaird A, et al. Facilitated hexose transporters: new perspectives on form and function. Physiology (Bethesda) 2007; 22: 234-240.
60. Montel-Hagen A, Kinet S, Manel N, et al. Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell 2008; 132: 1039-1048.
61. Dauchy RT, Xiang S, Mao L, et al. Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res 2014; 74: 4099-4110.